Yike Ya (易可亚)易可亚
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 重庆药友制药有限责任公司Chinese legal name: 重庆药友制药有限责任公司
主要成分Active Ingredients
- 膦甲酸 辅料为氯化钠Recorded Chinese composition: 膦甲酸 辅料为氯化钠
- 焦亚钠Jiaoya Na
- 依地酸钙钠Yidi Suangai Na
- 膦甲酸Linjia Suan
- 辅料为氯化钠Recorded Chinese composition: 辅料为氯化钠
药物知识说明
膦甲酸 辅料为氯化钠是一种在国家药监局注册认定的药品。该药品含有依地酸钙钠、焦亚钠-fc7495b5等成分。
该药品关联的活性成分包括：依地酸钙钠Yidi Suangai Na、焦亚钠Jiaoya Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：重庆药友制药有限责任公司Chinese legal name: 重庆药友制药有限责任公司。
您可以探索含有相同成分的其他药品：依地酸钙钠-a8445b32成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 易可亚) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 依地酸钙钠Yidi Suangai Na, 焦亚钠Jiaoya Na.
Manufacturers recorded for this product: 重庆药友制药有限责任公司Chinese legal name: 重庆药友制药有限责任公司.
Explore other medicines containing the same ingredient: 依地酸钙钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 易可亚Recorded Chinese name: 易可亚
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 100ml:2.4g100 mL:2.4 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 重庆药友制药有限责任公司Chinese legal name: 重庆药友制药有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20030125
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20030125
Manufacturer
Chinese legal name: 重庆药友制药有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20030125
生产企业
重庆药友制药有限责任公司(国产)
适应症
1.艾滋病（AIDS）患者巨细胞病毒性视网膜炎；|2.免疫功能损害患者耐阿昔洛韦单纯疱疹毒性皮肤粘膜感染。
用法用量
静脉滴注。剂量个体化。中心静脉输注：(注射液24mg/ml)可不需要稀释，直接使用。周围静脉输注：必须用5%葡萄糖或生理盐水稀释至12mg/ml后作用。1．艾滋病(AIDS)患者巨细胞病毒性视网膜炎(肾功能正常)。诱导治疗：推动初始量为60mg/kg,每8小时一次，静滴时间不得少于1小时，根据疗效连用2～3周。维持治疗：维持剂量为90～120mg/kg/日(按肾功能调整剂量)，静滴时间不得少于2小时。维持治疗期间，若病情加重，可重复诱导治疗及维持治疗过程。2．免疫功能损害患者耐阿昔洛韦单纯疱疹病毒(HSV)性皮肤粘膜感染。推荐剂量为40mg/kg,每8或12小时一次，静滴时间不得小于1小时，连用2～3周或直至治愈。肾功能不全者可参照下表应进行剂量调整(表1)肌酐清除率(ml/min/kg)诱导治疗巨细胞病毒维持治疗单纯疱疹病毒巨细胞病毒相当于180mg/kg/日相当于90mg/kg/日相当于120mg/kg/日相当于80mg/kg/日相当于120mg/kg/日＞1.440q12h40q8h60q8h90q24h120q24h＞1.0～1.430q12h30q8h45q8h70q24h90q24h＞0.8～1.020q12h36q12h50q12h50q24h65q24h＞0.6～0.836q24h25q12h40q12h80q48h105q48h＞0.5～0.625q24h40q24h60q24h60q48h80q48h≥0.4～0.520q24h35q24h50q24h50q48h65q48h＜0.4不推荐不推荐不推荐不推荐不推荐
不良反应
本品耐受性一般良好。常见的不良反应有恶心(23%～26%)、呕吐(13%～15%)、腹泻(13%～18%)、虚弱(9%～14%〕、腹痛(3%～7%)、厌食(1%～6%)、味觉异常(1%～10%)、感觉异常(3%～6%)。此外还有头痛、血管扩张和实验室化验异常，如三酰甘油(甘油三酯)与胆固醇、丙氨酸转氨酶与天冬氨酸转氨酶、尿酸值升高。本品不良反应发生率在治疗开始2～4周最大，因为在此时期内本品血浓度高。
禁忌
对膦甲酸钠过敏禁用。
贮藏
遮光，密闭保存。
规格
100ml:2.4g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.